Table 4.

Impact of treatment on other patient-reported outcomes

Relative per cent change from baseline in median patient-reported outcome	DR prednisone/ DMARD	Placebo/DMARD	Treatment difference (95% CI)	p Value
Days with recurrence of joint stiffness	−27.0	−7.1	−19.9 (−37.7 to −2.1)	0.03
Pain during the day (100 mm VAS)	−25.5	−31.7	−6.14 (−37.8 to 50.1)	0.78
Patient global assessment	−17.8	7.49	−25.3 (−44.6 to −5.9)	0.01
Days with analgesic use	−18.7	1.9	−20.6 (−37.3 to −4.0)	0.02

DMARD, disease-modifying antirheumatic drug; DR, delayed-release; VAS, visual analogue scale.